Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulconazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 10/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 9/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 9/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 6/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 6/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 6/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 4/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 4/20 | 1.00 |
| ▸ | CHRM3 | P20309 | 4/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 4/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 4/20 | 1.00 |
| ▸ | DRD3 | P35462 | 4/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 4/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 4/20 | 1.00 |
| ▸ | USP2 | O75604 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulconazole SCHEMBL34762 | 1.00 | IDO1 (1.00) | IDO1CYP3A4CYP2C9CYP1A2CYP2D6 | |
| Sulconazole SCHEMBL22123404 | 1.00 | IDO1 (1.00) | IDO1CYP3A4CYP2C9CYP1A2CYP2D6 | |
| Sulconazole SCHEMBL29923838 | 1.00 | IDO1 (1.00) | IDO1CYP3A4CYP2C9CYP1A2CYP2D6 | |
| Sulconazole SCHEMBL7600689 | 1.00 | IDO1 (1.00) | IDO1CYP3A4CYP2C9CYP1A2CYP2D6 | |
| Sulconazole SCHEMBL7600685 | 1.00 | IDO1 (1.00) | IDO1CYP3A4CYP2C9CYP1A2CYP2D6 | |
| Sulconazole SCHEMBL29194304 | 0.99 | IDO1 (0.98) | IDO1CYP3A4CYP2C9CYP1A2CYP2D6 | |
| Sulconazole SCHEMBL28462757 | 0.99 | IDO1 (0.98) | IDO1CYP3A4CYP2C9CYP1A2CYP2D6 | |
| SCHEMBL11698496 | 0.93 | IDO1 (0.87) | IDO1CYP3A4CYP2C9CYP1A2CYP2D6 | |
| SCHEMBL11699369 | 0.93 | IDO1 (0.87) | IDO1CYP3A4CYP2C9CYP1A2CYP2D6 | |
| SCHEMBL11693931 | 0.93 | IDO1 (0.87) | IDO1CYP3A4CYP2C9CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13412 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005693-A | Application of Jiaweidanzhi Xiaoyao powder or extract thereof in preparation of medicines for treating depression complicated with ulcerative colitis | 河南中医药大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260102419-A1 | USE OF COMPOUNDS IN THE TREATMENT OF FUNGAL INFECTIONS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2026-04-16 | — | — | US | claimed |
| EP-4719384-A2 | COMPOUNDS WITH ANTIFUNGAL PROPERTIES | Trustees of Dartmouth College (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4676500-A2 | MICROBIAL CONSORTIA | Kanvas Biosciences, Inc (US) | 2026-01-14 | — | — | EP | claimed |
| US-20260007753-A1 | DERMAL SKIN PROTECTANT AND CARRIER | INSPIRED MAT STRATEGIES LLC (US) | 2026-01-08 | — | — | US | claimed |
| US-20250387371-A1 | COMPOSITIONS AND FORMULATION METHODS FOR SUSTAINED LOCAL RELEASE OF ANTIFIBROTICS | THE HOPKINS UNIVERISTY (US) | 2025-12-25 | — | — | US | claimed |
| EP-4659014-A1 | EMULSION-BASED THICK-FILM ANTIFOULING COATING FOR HIGHLY SENSITIVE ELECTROCHEMICAL SENSING | President And Fellows Of Harvard College (US) | 2025-12-10 | — | — | EP | claimed |
| US-12419959-B2 | Dermal skin protectant and carrier | Inspired Material Strategies, LLC (US) | 2025-09-23 | — | — | US | claimed |
| EP-0310122-B1 | ANTIFUNGAL COMPOSITION | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1991-07-24 | — | — | EP | claimed |
| US-5028418-A | Miconazole, Econazole, Sulconazole | BRISTOL-MYERS SQUIBB COMPANY (US) | 1991-07-02 | — | — | US | claimed |
| US-5002938-A | Fungicide, Steroid, Alcohol and Diol and/or Triol Solvent, Hydroxyalkyl Cellulose | BRISTOL-MYERS SQUIBB COMPANY (US) | 1991-03-26 | — | — | US | claimed |
| WO-1991002497-A1 | TOPICAL NIFEDIPINE FOR CUTANEOUS, OCULAR, MUCOSAL HYPERSENSITIVITY, INFLAMMATORY AND HYPERPROLIFERATIVE CONDITIONS | BETH ISRAEL HOSPITAL ASSOCIATION (US) | 1991-03-07 | — | — | WO | claimed |
| WO-1991002527-A1 | METHOD AND COMPOSITION FOR THE TREATMENT OF CUTANEOUS, OCULAR, AND MUCOSAL HYPERSENSITIVITY, INFLAMMATION, AND HYPERPROLIFERATIVE CONDITIONS USING TOPICAL PREPARATIONS OF SEROTONIN ANTAGONISTS | BETH ISRAEL HOSPITAL ASSOCIATION (US) | 1991-03-07 | — | — | WO | claimed |
| EP-0310122-A1 | Antifungal composition | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1989-04-05 | — | — | EP | claimed |
| EP-0064283-B1 | STABILIZATION OF 1-SUBSTITUTED IMIDAZOLE DERIVATIVES IN TALC | SYNTEX (U.S.A.) INC. (US) | 1987-01-28 | — | — | EP | claimed |
| US-4277475-A | FOR BOTH MALES AND FEMALES | SYNTEX (U.S.A.) INC. (US) | 1981-07-07 | — | — | US | claimed |
| US-4247552-A | Contraceptive compositions and methods employing 1-substituted imidazole derivatives | SYNTEX (U.S.A.) INC. (US) | 1981-01-27 | — | — | US | claimed |
| US-4055652-A | 1-[β(R-thio)phenethyl]imidazoles and derivatives thereof | SYNTEX (U.S.A.) INC. (US) | 1977-10-25 | — | — | US | claimed |